News Image

Agenus to Provide Corporate Update and First Quarter 2022 Financial Report

Provided By Globe Newswire

Last update: Apr 26, 2022

LEXINGTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it will release its first quarter 2022 financial results before the market opens on Tuesday, May 10, 2022. Agenus executives will host a conference call and webcast at 8:30 a.m. ET the same day to discuss the results and to provide a corporate update.

Read more at globenewswire.com

AGENUS INC

NASDAQ:AGEN (7/14/2025, 8:21:52 PM)

Premarket: 6.7 -0.13 (-1.9%)

6.83

-0.23 (-3.26%)



Find more stocks in the Stock Screener

Follow ChartMill for more